The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...

European Commission president Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...

The Court of Justice of the EU will decide on Wednesday whether the European Commission had the authority to keep ...

EU Court will decide whether European Commission was right to withhold from the public text messages exchanged between its ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...